NCT04001400View on ClinicalTrials.gov

Treatment Response of High-dose and Standard-dose Rabeprazole for Extra-esophageal Reflux.

PHASE3CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

October 10, 2012

Primary Completion Date

May 21, 2014

Study Completion Date

May 21, 2014

Conditions
Esophageal Disease
Interventions
DRUG

Rabeprazole 20mg bid

Rabeprazole 20mg tablet b.i.d.

DRUG

Rabeprazole 20mg qd

Rabeprazole 20mg tablet q.d.

Trial Locations (1)

13620

Seoul National University Bungdang Hospital, Seongnam-si

Sponsors
All Listed Sponsors
collaborator

IlDong Pharmaceutical Co Ltd

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT04001400 - Treatment Response of High-dose and Standard-dose Rabeprazole for Extra-esophageal Reflux. | Biotech Hunter | Biotech Hunter